|
HCFC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.42659275690494E-14 |
| Normal-vs-Stage2 |
3.76609999996891E-06 |
| Normal-vs-Stage3 |
6.27276008913213E-14 |
| Normal-vs-Stage4 |
1.94666505137775E-12 |
| Stage1-vs-Stage2 |
2.178200E-01 |
| Stage1-vs-Stage3 |
1.413180E-01 |
| Stage1-vs-Stage4 |
2.515700E-02 |
| Stage2-vs-Stage3 |
3.574300E-02 |
| Stage2-vs-Stage4 |
1.133690E-02 |
| Stage3-vs-Stage4 |
4.470600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.044170E-04 |
| Normal-vs-Asian |
1.5279999487916E-09 |
| Caucasian-vs-AfricanAmerican |
1.832210E-01 |
| Caucasian-vs-Asian |
6.689400E-01 |
| AfricanAmerican-vs-Asian |
3.205000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.67121871896825E-12 |
| Male-vs-Female |
1.123850E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77091674657959E-12 |
| Normal-vs-Age(41-60Yrs) |
1.24299459614008E-11 |
| Normal-vs-Age(61-80Yrs) |
1.70696790036118E-12 |
| Normal-vs-Age(81-100Yrs) |
1.201940E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.428000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.954800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.645800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.029600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.109400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.313000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.618600E-04 |
| Classical-VS-Follicular |
1.588190E-01 |
| Classical-VS-Other |
1.350190E-01 |
| Classical-VS-Normal |
1.62536650805123E-12 |
| Tall-VS-Follicular |
2.645100E-04 |
| Tall-VS-Other |
8.889600E-01 |
| Tall-VS-Normal |
6.67244037799719E-14 |
| Follicular-VS-Other |
1.219180E-01 |
| Follicular-VS-Normal |
2.03389999997583E-06 |
| Other-VS-Normal |
6.42960000000192E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.12305736827057E-13 |
| Normal-vs-N1 |
2.86840551311229E-11 |
| N0-vs-N1 |
1.695230E-01 |
|
|
